Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.8/5
3SBio Inc (1530 HK)
Watchlist
Contact IR
115
Analysis
Health Care
•
China
3SBio, Inc. is a biotechnology company located in China. The Company focuses on mammalian cell-based biopharmaceuticals in the biotechnology industry. 3SBio also develops, manufactures and markets biopharmaceutical products globally.
more
Watchlist
Contact IR
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Thematic (Sector/Industry)
•
12 Sep 2016 15:18
Iran Shows China the Way on Population Expansion
Faced with dramatically falling birth rates, Iran has introduced a wide range of pro-natalist policies. In contrast, China has been half-hearted in...
Bixmoor
264 Views
Share
bearish
•
Thematic (Sector/Industry)
•
18 Aug 2016 10:43
Small Improvement in China Air Quality
Air quality in China appears to have improved slightly in recent months. However, it is still well above World Health Organisation recommended...
Bixmoor
285 Views
Share
bearish
•
Thematic (Sector/Industry)
•
04 Aug 2016 08:39
Critique of Genome Scientific Work
China’s state media reported this week that Han Chunyu’s scientific results on genome editing which were published in Nature Biotechnology in May...
Bixmoor
312 Views
Share
bearish
•
Thematic (Sector/Industry)
•
04 Aug 2016 08:05
China's Disconnect on Illegal Drugs
Senior Chinese officials regularly make all the appropriate noises about the evils of illicit drug use in China, but they seem unable to do...
Bixmoor
695 Views
Share
bearish
•
Thematic (Sector/Industry)
•
03 Aug 2016 12:21
Contradictory Stats on Breastfeeding
Breastfeeding rates in China are important, both in terms of stocks and for the health of the country. But how can we trust official statistics...
Bixmoor
241 Views
Share
First
Previous
17
18
19
20
21
22
23
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.6
x